Sec Form 13D Filing - TISCH THOMAS J filing for DMK PHARMACEUTICALS Corp (DMK) - 2010-02-16

Insider filing report for Changes in Beneficial Ownership

  • Schedule 13G & 13D forms are used to report a party's ownership of stock which exceeds 5% of a company's total stock issue.
  • Schedule 13G is a shorter version of Schedule 13D with fewer reporting requirements.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13D
Under the Securities Exchange Act of 1934
(Amendment No. 9)*


Adamis Pharmaceuticals Corporation 
(Name of Issuer)

Common Stock, par value $.0001 per share
(Title of Class of Securities)

15115L 10 3
(CUSIP Number)

Barry L. Bloom
655 Madison Avenue, 19th Floor
New York, NY 10021
(212) 521-2930
(Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)

N/A
(Date of Event which Requires Filing of this Statement)

If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of Rule 13d-1(e), 13d-1(f) or 13d-1(g), check the following box. [ ]
 
Note: Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See Rule 13d-7 for other parties to whom copies are to be sent.
 
*The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.
 
The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (the “Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).
 


SCHEDULE 13D

  
CUSIP No.   15115L 10 3      Page   2    of   14   Pages

  
1 NAME OF REPORTING PERSONS
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS

     Andrew H. Tisch
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions) (a)  [   ]
(b)  [X]
3 SEC USE ONLY
  
4 SOURCE OF FUNDS (See Instructions)

     PF
5
CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) OR 2(e)
 
[   ]
6 CITIZENSHIP OR PLACE OF ORGANIZATION

     United States
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON
WITH
7 SOLE VOTING POWER

     111,277
8 SHARED VOTING POWER

     -0-
9 SOLE DISPOSITIVE POWER

     111,277
10 SHARED DISPOSITIVE POWER

     -0-
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     111,277
12
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (See Instructions)
 
[   ]
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)

     0.0%
14
TYPE OF REPORTING PERSON (See Instructions)

     IN


SCHEDULE 13D

  
CUSIP No.   15115L 10 3      Page   3    of   14   Pages

  
1 NAME OF REPORTING PERSONS
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS

     Daniel R. Tisch
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions) (a)  [   ]
(b)  [X]
3 SEC USE ONLY
  
4 SOURCE OF FUNDS (See Instructions)

     PF
5
CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) OR 2(e)
 
[   ]
6 CITIZENSHIP OR PLACE OF ORGANIZATION

     United States
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON
WITH
7 SOLE VOTING POWER

     111,277
8 SHARED VOTING POWER

     -0-
9 SOLE DISPOSITIVE POWER

     111,277
10 SHARED DISPOSITIVE POWER

     -0-
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     111,277
12
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (See Instructions)
 
[   ]
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)

     0.0%
14
TYPE OF REPORTING PERSON (See Instructions)

     IN


SCHEDULE 13D

  
CUSIP No.   15115L 10 3      Page   4    of   14   Pages

  
1 NAME OF REPORTING PERSONS
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS

     James S. Tisch
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions) (a)  [   ]
(b)  [X]
3 SEC USE ONLY
  
4 SOURCE OF FUNDS (See Instructions)

     PF
5
CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) OR 2(e)
 
[   ]
6 CITIZENSHIP OR PLACE OF ORGANIZATION

     United States
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON
WITH
7 SOLE VOTING POWER

     111,277
8 SHARED VOTING POWER

     -0-
9 SOLE DISPOSITIVE POWER

     111,277
10 SHARED DISPOSITIVE POWER

     -0-
11 AGGREGATE AMOUNT BENEFICIAL LY OWNED BY EACH REPORTING PERSON

     111,277
12
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (See Instructions)
 
[   ]
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)

     0.0%
14
TYPE OF REPORTING PERSON (See Instructions)

     IN


SCHEDULE 13D

  
CUSIP No.   15115L 10 3      Page   5    of   14   Pages

  
1 NAME OF REPORTING PERSONS
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS

     Thomas J. Tisch
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions) (a)  [   ]
(b)  [X]
3 SEC USE ONLY
  
4 SOURCE OF FUNDS (See Instructions)

     PF
5
CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) OR 2(e)
 
[   ]
6 CITIZENSHIP OR PLACE OF ORGANIZATION

     United States
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON
WITH
7 SOLE VOTING POWER

     206,885
8 SHARED VOTING POWER

     -0-
9 SOLE DISPOSITIVE POWER

     206,885
10 SHARED DISPOSITIVE POWER

     -0-
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     206,885
12
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (See Instructions)
 
[   ]
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)

     0.0%
14
TYPE OF REPORTING PERSON (See Instructions)

     IN


SCHEDULE 13D

  
CUSIP No.   15115L 10 3      Page   6    of   14   Pages

  
1 NAME OF REPORTING PERSONS
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS

     Jessica S. Tisch
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions) (a)  [   ]
(b)  [X]
3 SEC USE ONLY
  
4 SOURCE OF FUNDS (See Instructions)

     PF
5
CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) OR 2(e)
 
[   ]
6 CITIZENSHIP OR PLACE OF ORGANIZATION

     United States
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON
WITH
7 SOLE VOTING POWER

     644
8 SHARED VOTING POWER

     -0-
9 SOLE DISPOSITIVE POWER

     644
10 SHARED DISPOSITIVE POWER

     -0-
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     644
12
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (See Instructions)
 
[   ]
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)

     0.0%
14
TYPE OF REPORTING PERSON (See Instructions)

     IN


SCHEDULE 13D

  
CUSIP No.   15115L 10 3      Page   7    of   14   Pages

  
1 NAME OF REPORTING PERSONS
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS

     Benjamin Tisch
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions) (a)  [   ]
(b)  [X]
3 SEC USE ONLY
  
4 SOURCE OF FUNDS (See Instructions)

     PF
5
CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) OR 2(e)
 
[   ]
6 CITIZENSHIP OR PLACE OF ORGANIZATION

     United States
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON
WITH
7 SOLE VOTING POWER

     644
8 SHARED VOTING POWER

     -0-
9 SOLE DISPOSITIVE POWER

     644
10 SHARED DISPOSITIVE POWER

     -0-
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     644
12
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (See Instructions)
 
[   ]
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)

     0.0%
14
TYPE OF REPORTING PERSON (See Instructions)

     IN


SCHEDULE 13D

  
CUSIP No.   15115L 10 3      Page   8    of   14   Pages

  
1 NAME OF REPORTING PERSONS
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS

     Samuel A. Tisch
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions) (a)  [   ]
(b)  [X]
3 SEC USE ONLY
  
4 SOURCE OF FUNDS (See Instructions)

     PF
5
CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) OR 2(e)
 
[   ]
6 CITIZENSHIP OR PLACE OF ORGANIZATION

     United States
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON
WITH
7 SOLE VOTING POWER

     644
8 SHARED VOTING POWER

     -0-
9 SOLE DISPOSITIVE POWER

     644
10 SHARED DISPOSITIVE POWER

     -0-
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     644
12
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (See Instructions)
 
[   ]
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)

     0.0%
14
TYPE OF REPORTING PERSON (See Instructions)

     IN


SCHEDULE 13D

  
CUSIP No.   15115L 10 3      Page   9    of   14   Pages

  
1 NAME OF REPORTING PERSONS
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS

     Thomas M. Steinberg
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions) (a)  [   ]
(b)  [X]
3 SEC USE ONLY
  
4 SOURCE OF FUNDS (See Instructions)

     PF
5
CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) OR 2(e)
 
[   ]
6 CITIZENSHIP OR PLACE OF ORGANIZATION

     United States
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON
WITH
7 SOLE VOTING POWER

     -0-
8 SHARED VOTING POWER

     -0-
9 SOLE DISPOSITIVE POWER

     -0-
10 SHARED DISPOSITIVE POWER

     -0-
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     -0-
12
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (See Instructions)
 
[   ]
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)

     0.0%
14
TYPE OF REPORTING PERSON (See Instructions)

     IN
 

This Amendment No. 9 to Schedule 13D amends and supplements the statement on Schedule 13D previously filed by Andrew H. Tisch, Daniel R. Tisch, James S. Tisch, Thomas J. Tisch, Jessica S. Tisch, Bemjamin Tisch, Samuel A. Tisch and Thomas M. Steinberg.  Except as amended and supplemented herein, that statement remains in full force and effect.
 
Item 1.                 Security and Issuer.
 
The equity securities to which this statement relates are shares of Common Stock, par value $.0001 per share, of Adamis Pharmaceuticals Corporation (formerly known as Cellegy Pharmaceuticals, Inc.), 2658 Del Mar Heights Road, #555, Del Mar, California 92014.
 
Item 5.                 Interest in Securities of the Issuer.
 
Item 5 is amended to read as follows:
 
As a result of a merger, each 9.92906033 shares of Common Stock previously held by the Reporting Persons were converted into one share of Common Stock.  As of the date hereof, the aggregate number of shares of Common Stock, including shares that may be acquired upon the exercise of Warrants, and the percentage of the outstanding shares of Common Stock (based upon 45,469,155 shares outstanding on November 20, 2009 as reported by the Issuer in its most recent Form 10-Q report) were as follows:
 


Name of Holder

Number of
Shares   
Percentage of
Outstanding
Shares

Four-Fourteen Partners, LLC (1)
Andrew H. Tisch
Daniel R. Tisch
James S. Tisch
Thomas J. Tisch
Andrew H. Tisch 1995 Issue Trust No. 1 (2)
Andrew H. Tisch 1995 Issue Trust No. 2 (2)
Daniel R. Tisch 1999 Issue Trust (2)
James S. Tisch 1995 Issue Trust (2)
Thomas J. Tisch 1994 Issue Trust (2)
Jessica S. Tisch
Benjamin Tisch
95,608
90,357
90,357
90,357
90,357
10,460
10,460
20,920
20,920
20,920
644
644
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%


Page 10 of 14 Pages
 

Samuel A. Tisch
Thomas M. Steinberg
644
0
0.0%
0.0%

               Total 542,648 1.2%

 
Each of the above persons who is a Reporting Person herein beneficially owns the number of shares set forth opposite his or her name.  Beneficial ownership of the other shares set forth in the above table has been determined as follows:
 
(1)
By virtue of his status as manager of Four-Fourteen Partners, LLC , Thomas J. Tisch may be deemed the beneficial owner of the shares owned by Four-Fourteen Partners, LLC and to have power to vote or direct the vote and dispose or direct the disposition of those shares.

(2)
By virtue of their status as trustees of their respective issue trusts, each of Andrew H. Tisch, Daniel R. Tisch, James S. Tisch and Thomas J. Tisch may be deemed to have beneficial ownership of shares owned by those trusts of which he is trustee and sole power to vote or direct the vote and dispose or direct the disposition of those shares.

 
Item 7. Material to Be Filed as Exhibits.

Exhibit 6. Agreement regarding the joint filing of this statement.
 
 
 
 
 
 
 
 
Page 11 of 14 Pages
 

SIGNATURE
 
            After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
 
February 16, 2010
 
    /s/ Andrew H. Tisch
      Andrew H. Tisch


     /s/ Daniel R. Tisch
      Daniel R. Tisch


     /s/ James S. Tisch
      James S. Tisch


     /s/ Thomas J. Tisch
      Thomas J. Tisch


     /s/ Jessica S. Tisch
      Jessica S. Tisch


     /s/ Benjamin Tisch
      Benjamin Tisch


     /s/ Samuel A. Tisch
      Samuel A. Tisch


     /s/ Thomas M. Steinberg
      Thomas M. Steinberg


 
 
 
 
Page 12 of 14 Pages
 

EXHIBIT INDEX
 
Exhibit 6. Agreement regarding the joint filing of this statement.
 
 
 
 
 
 
 
 
 
 
 
 
 
Page 13 of 14 Pages
 

AGREEMENT
 
            In accordance with Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, as amended, the undersigned hereby agree that this Amendment to Schedule 13D dated February 16, 2010 relating to the Common Stock, par value $.0001 per share, of Adamis Pharmaceuticals Corporation, are being filed with the Securities and Exchange Commission on behalf of each of them.
 
February 16, 2010
 
  /s/ Andrew H. Tisch
      Andrew H. Tisch


     /s/ Daniel R. Tisch
      Daniel R. Tisch


     /s/ James S. Tisch
      James S. Tisch


     /s/ Thomas J. Tisch
      Thomas J. Tisch


     /s/ Jessica S. Tisch
      Jessica S. Tisch


     /s/ Benjamin Tisch
      Benjamin Tisch


     /s/ Samuel A. Tisch
      Samuel A. Tisch


     /s/ Thomas M. Steinberg
      Thomas M. Steinberg
 
 
 


 

 
 


 

 

 
Page 14 of 14 Pages